Matthew Brougham Appointed CADTH Vice-President, Products and Services

September 15, 2011

Dr. Brian O’Rourke, President and Chief Executive Officer, CADTH, is pleased to announce the appointment of Matthew Brougham, Vice-President, Products and Services.

Matthew is responsible for overseeing CADTH’s key operational areas of health technology assessment, drug formulary reviews, the rapid response inquiry service, and optimal use recommendations and advice.

“As the former Chief Executive of PHARMAC in New Zealand, Matthew has expertise in promoting the appropriate use of pharmaceuticals and supporting evidence-based decision-making, which will make him a great addition to the leadership team at CADTH,” said Dr. O’Rourke.